These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19856660)

  • 1. Serotonin transporter 5-HTTLPR polymorphism and response to citalopram in terminally ill cancer patients: report of twenty-one cases.
    Capozzo MA; Schillani G; Aguglia E; De Vanna M; Grassi L; Conte MA; Giraldi T
    Tumori; 2009; 95(4):479-83. PubMed ID: 19856660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-HTTLPR polymorphism of serotonin transporter and effects of sertraline in terminally ill cancer patients: report of eleven cases.
    Schillani G; Capozzo MA; Aguglia E; De Vanna M; Grassi L; Conte MA; Giraldi T
    Tumori; 2008; 94(4):563-7. PubMed ID: 18822694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics of escitalopram and mental adaptation to cancer in palliative care: report of 18 cases.
    Schillani G; Capozzo MA; Era D; De Vanna M; Grassi L; Conte MA; Giraldi T
    Tumori; 2011; 97(3):358-61. PubMed ID: 21789016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression.
    Hu XZ; Rush AJ; Charney D; Wilson AF; Sorant AJ; Papanicolaou GJ; Fava M; Trivedi MH; Wisniewski SR; Laje G; Paddock S; McMahon FJ; Manji H; Lipsky RH
    Arch Gen Psychiatry; 2007 Jul; 64(7):783-92. PubMed ID: 17606812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin transporter polymorphism (5-HTTLPR) and citalopram effectiveness and side effects in children with depression and/or anxiety disorders.
    Kronenberg S; Apter A; Brent D; Schirman S; Melhem N; Pick N; Gothelf D; Carmel M; Frisch A; Weizman A
    J Child Adolesc Psychopharmacol; 2007 Dec; 17(6):741-50. PubMed ID: 18315446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additive effects of 5-HTTLPR (serotonin transporter) and tryptophan hydroxylase 2 G-703T gene polymorphisms on the clinical response to citalopram among children and adolescents with depression and anxiety disorders.
    Rotberg B; Kronenberg S; Carmel M; Frisch A; Brent D; Zalsman G; Apter A; Weizman A
    J Child Adolesc Psychopharmacol; 2013 Mar; 23(2):117-22. PubMed ID: 23510446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between serotonin transporter-linked polymorphic region and escitalopram antidepressant treatment response in Korean patients with major depressive disorder.
    Won ES; Chang HS; Lee HY; Ham BJ; Lee MS
    Neuropsychobiology; 2012; 66(4):221-9. PubMed ID: 23095326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moderation of antidepressant response by the serotonin transporter gene.
    Huezo-Diaz P; Uher R; Smith R; Rietschel M; Henigsberg N; Marusic A; Mors O; Maier W; Hauser J; Souery D; Placentino A; Zobel A; Larsen ER; Czerski PM; Gupta B; Hoda F; Perroud N; Farmer A; Craig I; Aitchison KJ; McGuffin P
    Br J Psychiatry; 2009 Jul; 195(1):30-8. PubMed ID: 19567893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-HTTLPR polymorphism of the serotonin transporter gene predicts non-remission in major depression patients treated with citalopram in a 12-weeks follow up study.
    Arias B; Catalán R; Gastó C; Gutiérrez B; Fañanás L
    J Clin Psychopharmacol; 2003 Dec; 23(6):563-7. PubMed ID: 14624186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of 5-HTTLPR and STin2 polymorphisms in the serotonin transporter gene on treatment effect of selective serotonin reuptake inhibitors in depressive patients.
    Smits KM; Smits LJ; Peeters FP; Schouten JS; Janssen RG; Smeets HJ; van Os J; Prins MH
    Psychiatr Genet; 2008 Aug; 18(4):184-90. PubMed ID: 18628680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonergic Regulation and Cognition after Stroke: The Role of Antidepressant Treatment and Genetic Variation.
    Damsbo AG; Kraglund KL; Buttenschøn HN; Johnsen SP; Andersen G; Mortensen JK
    Cerebrovasc Dis; 2019; 47(1-2):72-79. PubMed ID: 30844812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin transporter 5-HTTLPR polymorphism and escitalopram treatment response in patients with major depressive disorder.
    Jarčušková D; Tkáč I; Hlaváčová N; Yaluri AS; Kozárová M; Habalová V; Klimčáková L; Židzik J; Javorský M; Bednářová A
    BMC Psychiatry; 2024 Oct; 24(1):690. PubMed ID: 39407134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common selective serotonin reuptake inhibitor side effects in older adults associated with genetic polymorphisms in the serotonin transporter and receptors: data from a randomized controlled trial.
    Garfield LD; Dixon D; Nowotny P; Lotrich FE; Pollock BG; Kristjansson SD; Doré PM; Lenze EJ
    Am J Geriatr Psychiatry; 2014 Oct; 22(10):971-9. PubMed ID: 24021217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of serotonin transporter genetic variation to efficacy of escitalopram for generalized anxiety disorder in older adults.
    Lenze EJ; Goate AM; Nowotny P; Dixon D; Shi P; Bies RR; Lotrich FK; Rollman BL; Shear MK; Thompson PA; Andreescu C; Pollock BG
    J Clin Psychopharmacol; 2010 Dec; 30(6):672-7. PubMed ID: 21105279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphism of the 5-HT transporter and response to antidepressants: randomised controlled trial.
    Lewis G; Mulligan J; Wiles N; Cowen P; Craddock N; Ikeda M; Grozeva D; Mason V; Nutt D; Sharp D; Tallon D; Thomas L; O'Donovan MC; Peters TJ
    Br J Psychiatry; 2011 Jun; 198(6):464-71. PubMed ID: 21263010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoamine transporter gene polymorphisms and antidepressant response in koreans with late-life depression.
    Kim H; Lim SW; Kim S; Kim JW; Chang YH; Carroll BJ; Kim DK
    JAMA; 2006 Oct; 296(13):1609-18. PubMed ID: 17018806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin transporter triallelic genotype and response to citalopram and risperidone in dementia with behavioral symptoms.
    Dombrovski AY; Mulsant BH; Ferrell RE; Lotrich FE; Rosen JI; Wallace M; Houck PR; Mazumdar S; Pollock BG
    Int Clin Psychopharmacol; 2010 Jan; 25(1):37-45. PubMed ID: 19996755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the serotonin transporter gene locus in the response to SSRI treatment of major depressive disorder in late life.
    Seripa D; Pilotto A; Paroni G; Fontana A; D'Onofrio G; Gravina C; Urbano M; Cascavilla L; Paris F; Panza F; Padovani A; Pilotto A
    J Psychopharmacol; 2015 May; 29(5):623-33. PubMed ID: 25827644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender-specific association between serotonin transporter polymorphisms (5-HTTLPR and rs25531) and neuroticism, anxiety and depression in well-defined healthy Han Chinese.
    Chang CC; Chang HA; Fang WH; Chang TC; Huang SY
    J Affect Disord; 2017 Jan; 207():422-428. PubMed ID: 27788383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allelic variation in 5-HTTLPR and the effects of citalopram on the emotional neural network.
    Ma Y; Li B; Wang C; Zhang W; Rao Y; Han S
    Br J Psychiatry; 2015 May; 206(5):385-92. PubMed ID: 25745133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.